Devonian Health Group Inc.
DVHGF
$0.1438
-$0.0262-15.41%
| Weiss Ratings | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -12.85 | |||
| Price History | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.03% | |||
| 30-Day Total Return | 8.49% | |||
| 60-Day Total Return | 1.66% | |||
| 90-Day Total Return | 30.21% | |||
| Year to Date Total Return | 8.49% | |||
| 1-Year Total Return | -32.76% | |||
| 2-Year Total Return | -17.53% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -16.06% | |||
| 52-Week Low % Change | 1,337.50% | |||
| Price | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.17 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Jul 23, 2024 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 19.06M | |||
| Enterprise Value | 11.98M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -75.63% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.30 | |||
| Price/Book (Q) | 2.05 | |||
| Enterprise Value/Revenue (TTM) | 1.15 | |||
| Price | $0.14 | |||
| Enterprise Value/EBITDA (TTM) | 425.30 | |||
| Enterprise Value/EBIT | -46.05 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 148.22M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 514 248 7509 | |||
| Address | 360, rue des Entrepreneurs Québec, QC G5V 4T1 | |||
| Website | groupedevonian.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2.49% | |||
| Profit Margin | -3.94% | |||
| Management Effectiveness | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.36% | |||
| Return on Equity | -- | |||
| Income Statement | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 16.42M | |||
| Total Revenue (TTM) | 16.42M | |||
| Revenue Per Share | $0.11 | |||
| Gross Profit (TTM) | 5.26M | |||
| EBITDA (TTM) | 44.40K | |||
| EBIT (TTM) | -410.10K | |||
| Net Income (TTM) | -647.40K | |||
| Net Income Avl. to Common (TTM) | -647.40K | |||
| Total Revenue Growth (Q YOY) | 357.27% | |||
| Earnings Growth (Q YOY) | 50.14% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 51.35% | |||
| Balance Sheet | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 8.94M | |||
| Cash Per Share (Q) | $0.06 | |||
| Total Current Assets (Q) | 15.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 10.40M | |||
| Current Ratio (Q) | 1.129 | |||
| Book Value Per Share (Q) | $0.07 | |||
| Total Assets (Q) | 23.93M | |||
| Total Current Liabilities (Q) | 13.44M | |||
| Total Debt (Q) | 1.63M | |||
| Total Liabilities (Q) | 13.52M | |||
| Total Common Equity (Q) | 10.40M | |||
| Cash Flow | DVHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -15.80K | |||
| Cash from Financing (TTM) | -993.90K | |||
| Net Change in Cash (TTM) | 5.47M | |||
| Levered Free Cash Flow (TTM) | 6.68M | |||
| Cash from Operations (TTM) | 6.48M | |||
